{
    "2020-04-21": [
        [
            {
                "time": "",
                "original_text": "贝达药业2019年度净利润2.31亿元 “埃克替尼”累计销售破70亿元",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "2019年度",
                        "净利润",
                        "2.31亿元",
                        "埃克替尼",
                        "累计销售",
                        "70亿元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "拟10股派1.9元，贝达药业去年净利涨38.37%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "10股派1.9元",
                        "净利",
                        "38.37%"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：2019年度净利润升38.37%至2.31亿元 拟10派1.9元",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "300558.SZ",
                        "2019年度",
                        "净利润",
                        "38.37%",
                        "2.31亿元",
                        "10派1.9元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【天风医药】贝达药业：年报业绩符合预期，公司开始步入收获期",
                "features": {
                    "keywords": [
                        "天风医药",
                        "贝达药业",
                        "年报",
                        "业绩",
                        "符合预期",
                        "收获期"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}